Càrniques Celrà, SL

What Càrniques Celrà, SL does

Càrniques Celrà, S.L. is a Spanish pork processing and export company founded in October 2011 and headquartered in Celrà, Girona, approximately 50 km from the French border. The company operates a single processing facility of 50,000 m² total surface area (27,700 m² built) with 1,000 m³ of freezing tunnel capacity, 26,000 m³ of cold storage, and 10,000 m³ of refrigeration. Current production stands at 5,200 pigs per day with stated headroom to grow to 7,000 pigs per day, yielding approximately 120,000 metric tonnes of meat per year. The company is a wholly-owned subsidiary of the family-owned Olot Meats Group, alongside Olot Meats S.A. and Càrniques de Juià S.A., collectively operating 15,000 pigs per day across 1,500 employees and €725 million in annual group revenue.

The core business is B2B export of fresh and frozen pork cuts to international food importers and distributors in 118+ countries, with prices negotiated bilaterally against prevailing market rates. The company runs an enterprise field-sales motion staffed by country-specific representatives who develop customized product specifications, catalogs, and welcome presentations per destination market. Its core technology stack is an ISO-certified quality management system with HACCP (Hazard Analysis and Critical Control Points) for food safety, supplemented by a proprietary 'made-to-measure' pig genetics program developed in cooperation with the group and a 100% Spanish-born-and-fattened pig supply chain for traceability. Beyond pork, Càrniques Celrà has diversified into two adjacent verticals: Glicopepton, a pharmaceutical product line launched in October 2022 that uses pork-derived compounds, and a biofuel production line announced for November 2025 that valorizes pork fat as feedstock.

Càrniques Celrà sells exclusively to other businesses — there is no consumer-facing channel — and participates in major international food trade fairs (including ANUGA 2025 in Cologne) for demand generation. The company is privately held, is registered as a Sociedad Limitada in Spain, and is led at the group level by Mikel Soraluze (Founder and President of Olot Meats Group). No external private equity, venture capital, or institutional investment is disclosed in the input data.

Name

Càrniques Celrà, SL

Legal name

Càrniques Celrà, S.L.

Website

https://ccelra.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Càrniques Celrà, S.L. is a Spanish B2B pork processor and exporter, part of the Olot Meats Group, slaughtering 5,200 pigs per day for fresh and frozen cut export to distributors in 118+ countries, with adjacent pharmaceutical (Glicopepton) and biofuel lines.

Ownership category

akta.pro rank

Product category

Pork Processing

NAICS

Animal (except Poultry) Slaughtering (311611), Meat Processed from Carcasses (311612)

SIC

Meat Packing Plants (2011)

akta.pro industry

PRIMARYAFANABAB

Pork Fabrication & Primals Cutting (Carcass Breakdown)

Agriculture & Food Production/Meat, Poultry & Seafood Processing/Pork Processing (Slaughtering, Fabrication & Packaging)

SECONDARYAFANABAJ

By-Product & Offal Processing (Edibles: Variety Meats)

Agriculture & Food Production/Meat, Poultry & Seafood Processing/Pork Processing (Slaughtering, Fabrication & Packaging)

Keywords

• Pork meat processing
• Fresh pork cuts
• Frozen pork export
• Meat industry
• Pharmaceutical byproducts

Headquarters

HQ city

Celrà

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Meat Processing and Export: Core business of slaughtering, cutting, processing, and exporting pork products to international markets. Products include fresh and frozen pork cuts with customized specifications for different countries.
2. Pharmaceutical Industry (Glicopepton): Entry into pharmaceutical industry with Glicopepton product line, utilizing meat-derived compounds for pharmaceutical applications.
3. Biofuel Production: Integration into biofuel production using pork fat as raw material, diversifying revenue streams through waste valorization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Càrniques Celrà, S.L. is a Spanish pork processor that slaughters, cuts, processes, and exports fresh and frozen pork cuts under customized country-specific specifications to importers and distributors in more than 118 countries. The company also produces Glicopepton, a pork-derived pharmaceutical by-product, and operates within the family-owned Olot Meats Group.

Product overview

Càrniques Celrà, SL is a meat processing company that operates as part of the OLOT MEATS GROUP. The company offers core meat/pork processing services and products, including fresh and frozen pork cuts. Their product portfolio includes a specialized sub-product called Glicopepton, which represents the company's diversification into the pharmaceutical industry. The company operates a single-plant facility with a production capacity of 5,200 pigs per day, expandable to 7,000, and exports to over 120 countries. The core products consist of pork meat cuts and by-products, with Glicopepton serving as a distinct specialized offering.

Differentiator

Problem solved

Functional benefit

Brands

• Glicopepton: A pharmaceutical product line developed by Càrniques Celrà, representing the company's entry into the pharmaceutical industry.

Products and services

• Fresh and Frozen Pork Cuts Fresh and frozen pork cuts produced from pigs born and fattened in Spain, with customized cutting, polishing, packaging, and conservation specifications tailored per destination country. Supplied to international importers and distributors across 118+ authorized export markets under ISO + HACCP-certified quality management.
• Glicopepton A specialized product derived from pork processing that represents Càrniques Celrà's entry into the pharmaceutical industry, leveraging meat-derived compounds for pharmaceutical applications.

Quantifiable outcome

• 100% born and fattened in Spain - controlled pig purchasing

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Biofuel Production PartnerscoreStrategic or Co-development Partner · 10 November 2025Olot Meats Group integration into biofuel production using pork fat as raw material, representing sustainable waste valorization and diversification of business activities.
• Olot Meats, S.A.coreOthersParent company within Olot Meats Group. Càrniques Celrà is part of a group with combined production of 15,000 pigs/day, €725M annual revenue, and 1,500 employees across three companies.
• Càrniques de Juià, S.A.coreOthersSister company within Olot Meats Group. One of three companies making up one of Spain's most powerful meat groups.

Scale indicators11 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Patel Group (Patel Food Products): International halal meat processor active in European pork and beef exports with growing global reach. Comparable as a mid-sized export-oriented meat processor pursuing regulatory diversification across many destination markets.

Broad incumbents

• Campofrío Food Group: One of Europe's largest processed meat companies (now part of Sigma Foods), headquartered in Spain with broad branded and private-label pork product portfolios. Comparable in Spanish pork processing scale and export reach, though broader in product scope (includes poultry, ready meals).
• Vion Food Group: Major Dutch meat processor with significant European pork operations and global export reach. Comparable in pork slaughtering and processing capability, regulatory compliance systems, and B2B export model to international markets.
• Danish Crown: European cooperative and one of the world's largest pork exporters, headquartered in Denmark. Highly comparable business model focused on slaughtering, cutting, and exporting pork globally with strong regulatory and quality positioning.
• Tönnies Holding: Germany's largest pork processor, vertically integrated from slaughtering through packaged meat products. Comparable in European pork processing scale, B2B sales model, and export orientation, though broader in product and geographic reach.

Direct peers

• ElPozo Alimentación: Major Spanish pork processor and branded meat products company with vertically integrated operations. Comparable as a domestic Spanish pork heavyweight competing in similar fresh and processed pork categories for both retail and export channels.
• Càrniques de Juià, S.A. Third operating company of Olot Meats Group, focused on pork processing in the Girona region of Spain. Most directly comparable peer, sharing parent group, regulatory footprint, customer base, and operational model.
• Grupo Jorge: Spanish integrated pork producer operating slaughter, cutting, and processing facilities with significant export presence. Highly comparable in product portfolio, B2B export model, and Iberian geographic footprint.
• Olot Meats, S.A. Sister company within Olot Meats Group, also engaged in pork slaughtering and processing in Spain. Directly comparable in product, geography, and operating model; the two share infrastructure, management, and customer relationships within the same parent group.

Regional players

• Frimesa Cooperativa: Spanish pork processor (Catalonia region) with slaughtering and processing operations. Comparable in Iberian pork processing model though operating at smaller scale and with more regional customer focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/c%C3%A0rniques-celr%C3%A0-sl

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Càrniques Celrà, SL